Case report: Atypical spindle cell/pleomorphic lipomatous tumor masquerading as a myxoid liposarcoma or intramuscular myxoma

Bibliographic Details
Title: Case report: Atypical spindle cell/pleomorphic lipomatous tumor masquerading as a myxoid liposarcoma or intramuscular myxoma
Authors: Jiro Ichikawa, Tomonori Kawasaki, Hiroki Imada, Satoshi Kanno, Naofumi Taniguchi, Tomoyuki Ashizawa, Hirotaka Haro
Source: Frontiers in Oncology, Vol 12 (2022)
Publisher Information: Frontiers Media S.A., 2022.
Publication Year: 2022
Collection: LCC:Neoplasms. Tumors. Oncology. Including cancer and carcinogens
Subject Terms: atypical spindle cell/pleomorphic lipomatous tumor, differential diagnosis, magnetic resonance imaging, histopathology, immunohistochemistry, fluorescence in situ hybridization, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282
More Details: Atypical spindle cell/pleomorphic lipomatous tumors (ASPLTs) were recently categorized as benign lipomatous tumors. However, accurate and complete preoperative diagnosis of ASPLTs may be difficult. Furthermore, diagnosis based on magnetic resonance imaging (MRI) findings is uncertain because of the varying ratios of the fat component within the tumor. Here, we report a case of ASPLT masquerading as a myxoid tumor. Although MRI findings were consistent with a myxoid liposarcoma, needle biopsy findings suggested a myxoma, and we performed marginal resection. Histopathological findings revealed infiltrating spindle cells with atypia. In addition, immunohistochemistry (IHC) showed positive staining for CD34 and heterogeneous retinoblastoma deficiency, and fluorescence in situ hybridization (FISH) showed no amplification of mouse double minute 2 homolog and no rearrangement of FUS or EWSR1. When MRI and histopathological findings suggest a myxoid tumor, IHC and FISH should be considered and performed for a precise and accurate diagnosis.
Document Type: article
File Description: electronic resource
Language: English
ISSN: 2234-943X
Relation: https://www.frontiersin.org/articles/10.3389/fonc.2022.1033114/full; https://doaj.org/toc/2234-943X
DOI: 10.3389/fonc.2022.1033114
Access URL: https://doaj.org/article/70f57de71d28442398bfad7b7f7689d9
Accession Number: edsdoj.70f57de71d28442398bfad7b7f7689d9
Database: Directory of Open Access Journals
More Details
ISSN:2234943X
DOI:10.3389/fonc.2022.1033114
Published in:Frontiers in Oncology
Language:English